EP2094700
CRYSTALLINE MONOTOSYLATE SALT OF 2-METHYL-2-[4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-2,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-1-YL)-PHENYL]-PROPIONITRILE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.11.2007EP published:
2.4.2014EP application number:
07864492.9
EPO information:
European Patent Register
Max expiry date:
15.11.2027
Title:
CRYSTALLINE MONOTOSYLATE SALT OF 2-METHYL-2-[4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-2,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-1-YL)-PHENYL]-PROPIONITRILE
Timeline
Today
16.11.2007EP application
2.4.2014EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
STOWASSER, FrankAddress:
Murg, DE
Name:
BÄNZIGER, MarkusAddress:
Bubendorf, CH
Name:
GARAD, Sudhakar DevidasraoAddress:
Malden, Massachusetts, US
Priority
Number:
866483 PDate:
20.11.2006Country:
US
Classification
Categories:
C07D 471/04, A61K 31/4745, A61P 35/00